These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36196692)

  • 1. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.
    Nomura A
    Hypertens Res; 2023 Sep; 46(9):2126-2134. PubMed ID: 37258624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the future of health care with AI-driven digital therapeutics.
    Vasdev N; Gupta T; Pawar B; Bain A; Tekade RK
    Drug Discov Today; 2024 Sep; 29(9):104110. PubMed ID: 39034025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Therapeutics in Hearing Healthcare: Evidence-Based Review.
    Kim N; Nakamura KA
    J Audiol Otol; 2024 Jul; 28(3):159-166. PubMed ID: 38973323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.
    Prodan A; Deimel L; Ahlqvist J; Birov S; Thiel R; Toivanen M; Kolitsi Z; Kalra D
    Front Med (Lausanne); 2022; 9():854665. PubMed ID: 35492346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
    Sim B; Ju JH; Kim B; Lee JY
    JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital Therapies (DTx) as New Tools within Physicians' Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use.
    Bélisle-Pipon JC; David PM
    Pharmaceut Med; 2023 Mar; 37(2):121-127. PubMed ID: 36653600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital therapeutics in hypertension: How to make sustainable lifestyle changes.
    Chen C; Liu A; Zhang Z; Chen J; Huang H
    J Clin Hypertens (Greenwich); 2024 Oct; 26(10):1125-1132. PubMed ID: 39248244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.
    Biskupiak Z; Ha VV; Rohaj A; Bulaj G
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities.
    Hosono T; Niwa Y; Kondoh M
    Ther Innov Regul Sci; 2024 Sep; ():. PubMed ID: 39306603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Revolution of Digital Therapeutics (DTx) in the Pharmaceutical Industry and Their Quality Impacts.
    Rajendran A; Kella A; Narayanasamy D
    Cureus; 2024 Aug; 16(8):e66792. PubMed ID: 39268306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding patient perspectives on digital therapeutics and its platform for insomnia: insights from focused group interviews.
    Kim J; Park KM; Lee S; Park S; Hong M; Shin J; Lee E
    BMC Health Serv Res; 2024 Jul; 24(1):859. PubMed ID: 39075544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing face of healthcare: digital therapeutics in the management of diabetes.
    Ramakrishnan P; Yan K; Balijepalli C; Druyts E
    Curr Med Res Opin; 2021 Dec; 37(12):2089-2091. PubMed ID: 34511002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the potential of digital therapeutics: An assessment of progress and promise.
    Armeni P; Polat I; De Rossi LM; Diaferia L; Meregalli S; Gatti A
    Digit Health; 2024; 10():20552076241277441. PubMed ID: 39291152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewiring care delivery through Digital Therapeutics (DTx): a machine learning-enhanced assessment and development (M-LEAD) framework.
    Carrera A; Manetti S; Lettieri E
    BMC Health Serv Res; 2024 Feb; 24(1):237. PubMed ID: 38395905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.
    Rodler S; Kowalewski KF; Scheibert H; Bensel M; Stadelmeier LF; Styn A; Belenchon IR; Taratkin M; Puliatti S; Gomez Rivas J; Veccia A; Piazza P; Checcucci E; Michel MS; Stief CG; Cacciamani G;
    Eur Urol Open Sci; 2023 Sep; 55():23-27. PubMed ID: 37593208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the key drivers of the Japanese digital therapeutics patents: A cross-sectional study.
    Oda T; Oda C
    Health Sci Rep; 2023 Jun; 6(6):e1268. PubMed ID: 37275666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptualizing socially-assistive robots as a digital therapeutic tool in healthcare.
    Stanojevic C; Bennett CC; Sabanovic S; Collins S; Baugus Henkel K; Henkel Z; Piatt JA
    Front Digit Health; 2023; 5():1208350. PubMed ID: 37519896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring.
    Kim M; Patrick K; Nebeker C; Godino J; Stein S; Klasnja P; Perski O; Viglione C; Coleman A; Hekler E
    J Med Internet Res; 2024 Mar; 26():e49208. PubMed ID: 38441954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.